Steven Brem (born September 1947) is a board-certified American neurosurgeon in Philadelphia, Pennsylvania. He subspecializes in brain and spinal tumor, pituitary surgery and skull base.
Steven Brem Facts
- Full Name: Steven Brem
- Age: 65 years old
- Date of Birth: September 1947
- Occupation: Neurosurgeon
- Nationality: American
Steven Brem Medical School & Residency
- Harvard Medical School – Certificate, Surgical Leadership, 2018-2019
- Massachusetts General Hospital – Residency, Neurological Surgery, 1980-1981
- New York Presbyterian Hospital – Residency, Neurological Surgery, 1979-1980
- Massachusetts General Hospital – Residency, Neurological Surgery, 1977-1979
- Massachusetts General Hospital – Residency, Neurological Surgery, 1973-1974
- Massachusetts General Hospital – Internship, Transitional Year, 1972-1973
- Harvard Medical School – Medical School
Certifications & Licensure
- American Board of Neurological Surgery – Certified in Neurological Surgery
- NY State Medical License – Active through 1992
- IL State Medical License – Active through 2002
- FL State Medical License – Active through 2012
- PA State Medical License – Active through 2022
- NJ State Medical License – Active through 2021
Hospital Affiliations
- Good Shepherd Penn Partners Specialty Hospital at Rittenhouse, Philadelphia, PA
- Hospitals of the University of Pennsylvania-Penn Presbyterian, Philadelphia, PA
- Penn Presbyterian Medical Center, Philadelphia, PA
- Pennsylvania Hospital, Philadelphia, PA
- Doylestown Hospital, Doylestown, PA
Specialty Expertise
Steven Brem has the following 20 areas of expertise
- biopsy of brain
- brain cancer genomics
- craniotomy
- stereotactic ablative radiotherapy
- stereotactic brain biopsy
- stereotactic radiosurgery
Insurance Accepted
- Cigna
- Geisinger Health Plan
Location & Contact Information
Penn Neuroscience Center – Neurosurgery
3400 Civic Center Boulevard South Pavilion, 2nd Floor
Philadelphia, PA 19104
(215) 316-5151
Clinical Trials
- Effect of TTFields (150 kHz) in Non-small Cell Lung Cancer (NSCLC) Patients With 1-10 Brain Metastases Following Radiosurgery (METIS)
- Vigilant ObservatIon of GlIadeL WAfer ImplaNT Registry
- Validation of Edema-invariant Multi-shell High Angular Resolution Diffusion Imaging (msHARDI)-Based Tractography With Intra-operative Cortical Stimulation
- The Toca 5 Trial: Toca 511 & Toca FC Versus Standard of Care in Patients With Recurrent High Grade Glioma
- Expanded Access Protocol for GBM Patients With Already Manufactured DCVax®-L Who Have Screen-Failed Protocol 020221
Steven Brem Net Worth
Steven Brem has an estimated networth of $3 million.
